Variable | Categories | Risk of positive blood smear on day 1 | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|---|---|
RR* (95% CI) | p-value | RR†(95% CI) | p-value | |||
Anti-malarial treatment | DP | 52.2% | 1.0 (reference) | - | 1.0 (reference) | - |
 | AL | 67.6% | 1.30 (1.13-1.49) | <0.001 | 1.35 (1.21-1.50) | <0.001 |
mg/kg dosing of anti-malarial | ≥ median (DP) | 55.0% | 1.0 (reference) | - | Not included in final model | |
 | < median (DP) | 49.4% | 0.96 (0.78-1.18) | 0.68 |  |  |
 | ≥ median (AL) | 64.3% | 1.0 (reference) | - |  |  |
 | < median (AL) | 70.7% | 1.11 (0.96-1.28) | 0.16 |  |  |
Temperature °C | < 37.0 | 48.2% | 1.0 (reference) | - | 1.0 (reference) | - |
 | 37.0-37.9 | 59.7% | 1.22 (1.03-1.44) | 0.02 | 1.09 (0.96-1.24) | 0.19 |
 | ≥ 38.0 | 71.2% | 1.47 (1.25-1.73) | <0.001 | 1.17 (1.04-1.33) | 0.01 |
Parasite density per μL | < 4,000 | 21.3% | 1.0 (reference) | - | 1.0 (reference) | - |
 | 4,000-20,000 | 57.4% | 2.64 (1.93-3.63) | <0.001 | 2.62 (1.90-3.62) | <0.001 |
 | > 20,000 | 73.5% | 3.39 (2.51-4.59) | <0.001 | 3.31 (2.44-4.49) | <0.001 |
Haemoglobin g/dL | ≥ 10 | 60.0% | 1.0 (reference) | - | Not included in final model | |
 | < 10 | 64.0% | 1.08 (0.92-1.26) | 0.33 |  |  |
HIV status | Negative | 60.5% | 1.0 (reference) | - | Not included in final model | |
 | Positive | 58.3% | 0.97 (0.72-1.31) | 0.84 |  |  |
Episode number | 1-2 | 59.9% | 1.0 (reference) | Â | Not included in final model | |
 | 3-4 | 57.1% | 0.94 (0.82-1.09) | 0.42 |  |  |
 | ≥ 5 | 65.0% | 1.02 (0.90-1.17) | 0.74 |  |  |